← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Intralytix, Inc.
Baltimore, MD
$9,066,241
Total funding
4
Grants
Funding over time
peak $2.7M · FY2007–24$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,066,241 · 4
By mechanism
U01$6,899,363 · 1
N43$1,797,717 · 1
R43$269,232 · 1
R41$99,929 · 1
Investigators at Intralytix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Bacteriophage-based approach for managing Shigella infections$1,952,644
U01 · FY2020 · AI
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications$1,498,045
N44 · FY2022 · AI
Bacteriophage-based approach for managing Shigella infections$1,439,728
U01 · FY2021 · AI
Bacteriophage-based approach for managing Shigella infections$1,172,622
U01 · FY2023 · AI
Bacteriophage-based approach for managing Shigella infections$1,171,611
U01 · FY2022 · AI
Bacteriophage-based approach for managing Shigella infections$1,162,758
U01 · FY2024 · AI
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications$299,672
N43 · FY2021 · AI
Bacteriophage-based probiotic preparations and their effect on the gut microflora$269,232
R43 · FY2007 · AT
LIMITATION OF SALMONELLA COLONIZATION WITH PHAGE THERAPY$99,929
R41 · FY2000 · AI